William C. Shakespeare
2021
In 2021, William C. Shakespeare earned a total compensation of $1.8M as Co-Founder, President of Research and Development at Theseus Pharmaceuticals, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $188,555 |
|---|---|
| Option Awards | $1,112,055 |
| Salary | $452,038 |
| Total | $1,752,648 |
Shakespeare received $1.1M in option awards, accounting for 63% of the total pay in 2021.
Shakespeare also received $188.6K in non-equity incentive plan and $452K in salary.
Rankings
In 2021, William C. Shakespeare's compensation ranked 6,576th out of 12,406 executives tracked by ExecPay. In other words, Shakespeare earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,576 out of 12,406 | 47th |
Division Manufacturing | 2,834 out of 5,492 | 48th |
Major group Chemicals And Allied Products | 1,248 out of 2,368 | 47th |
Industry group Drugs | 1,113 out of 2,089 | 47th |
Industry Pharmaceutical Preparations | 806 out of 1,536 | 48th |
Source: SEC filing on April 25, 2022.
Shakespeare's colleagues
We found four more compensation records of executives who worked with William C. Shakespeare at Theseus Pharmaceuticals in 2021.